Delivery Order SPE2DB22D1200-SPE2DB24FN4LY
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $35,544.41, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron HCL 4 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a range of medical commodities to support military healthcare. This contract does...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $11,566.08 for the supply of 4,565,520,865 units of the medication ondansetron hydrochloride 4 mg tablets. The contract is a firm fixed price agreement with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. This delivery order is likely part of a...
The Defense Logistics Agency (DLA) awarded a $1,029.66 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,749,615 units of the drug Ondansetron HCl 4 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
This federal contract award, valued at $6,387.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,754,560 units of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,959.47 firm-fixed-price delivery order is for the supply of 4,565,697.865 units of the drug Ondansetron HCl 4 mg tablets in 500-count bottles. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,787.18, is for the delivery of 4,566,947,023 units of Ondansetron HCL 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of January 16, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,566,166,114 units of Ondansetron HCL 4 mg tablets, with a ceiling value of $15,834.86 and a completion date of October 22, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, worth $1,440.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,689,323 units of Ondansetron ODT 4 mg tablets in 30-count packs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,563,358,978 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $12,144.43 and an ultimate completion date of January 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supply chain services. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,066,804 units of the prescription drug Ondansetron Hydrochloride 4 mg Tablets. The delivery order contract has a firm fixed price of $8,088.22 and a completion date of October 10, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its corporate office division, will provide these...